Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Hemoglobin and 25-hydroxyvitamin D levels did not differ significantly between groups.

Source: Baseline characteristics according to sarcopenia status. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study was a secondary analysis of pre-existing cross-sectional clinical survey data.

Source: Methods.

Participants were classified into the sarcopenia and non-sarcopenia groups according to the diagnostic criteria for sarcopenia.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between sarcopenia and fall history in middle-aged and older adults: a multidimensional clinical analysis of nutritional status, bone health, and medication burden

Secondary analysis · Frontiers in Endocrinology · 2026

Original publication title

Association between sarcopenia and fall history in middle-aged and older adults: a multidimensional clinical analysis of nutritional status, bone health, and medication burden

Pin Wang; Jie Ke; Jingjing Wang; Jingyan Chen; Lei Zhang; Yan Yang

Copyright © 2026 Wang, Ke, Wang, Chen, Zhang and Yang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Sarcopenia was significantly associated with fall history in middle-aged and older adults, independent of nutritional status, osteoporosis, comorbidity burden, and polypharmacy. Low muscle mass and smaller calf circumference were the sarcopenia-related components most clearly associated with fall history. These findings support the importance of evaluating sarcopenia-related fall susceptibility.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Sarcopenia has been associated with an increased risk of falls in older adults; however, this association may be influenced by nutritional status, bone health, comorbidity burden, and medication use. This study aimed to investigate the association between sarcopenia and fall history in middle-aged and older adults and to further identify sarcopenia-related components associated with fall history.

Source: Background

Abstract: What methods does the paper describe?

This cross-sectional clinical study included 298 middle-aged and older inpatients who underwent sarcopenia assessment, fall history collection, anthropometric measurements, nutritional assessment, laboratory testing, and bone health evaluation. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia 2019 criteria. Fall history was defined as at least one self-reported fall in the past 12 months prior to assessment. Binary logistic regression models were used to evaluate the association between sarcopenia and fall history, with progressive adjustment for age, sex, BMI, number of comorbidities, polypharmacy, Mini Nutritional Assessment total score, and osteoporosis status.

Associations between individual sarcopenia-related components and fall history were further examined.

Source: Methods

Abstract: Results

Among the 298 participants, 125 were classified as having sarcopenia and 73 had a history of falls. Participants with sarcopenia had a higher prevalence of fall history than those without sarcopenia (32.0% vs. 19.1%, P = 0.010). In the fully adjusted model, sarcopenia remained significantly associated with fall history after adjustment for age, sex, BMI, comorbidity burden, polypharmacy, nutritional status, and osteoporosis (OR = 3.548, 95% CI 1.682 to 7.482, P = 0.001). In component analyses, lower appendicular skeletal muscle mass index (OR = 1.948 per 1 kg/m² decrease, 95% CI 1.190 to 3.191, P = 0.008), low muscle mass (OR = 2.799, 95% CI 1.467 to 5.340, P = 0.002), and smaller calf circumference (OR = 1.180 per 1 cm decrease, 95% CI 1.049 to 1.326, P = 0.006) were significantly associated with fall history.

Handgrip strength, low handgrip strength, gait speed, and low gait speed were not significantly associated with fall history.

Source: Results

Abstract: Conclusion

Sarcopenia was significantly associated with fall history in middle-aged and older adults, independent of nutritional status, osteoporosis, comorbidity burden, and polypharmacy. Low muscle mass and smaller calf circumference were the sarcopenia-related components most clearly associated with fall history. These findings support the importance of evaluating sarcopenia-related fall susceptibility.

Source: Conclusion
Authors’ abstract

Background

Sarcopenia has been associated with an increased risk of falls in older adults; however, this association may be influenced by nutritional status, bone health, comorbidity burden, and medication use. This study aimed to investigate the association between sarcopenia and fall history in middle-aged and older adults and to further identify sarcopenia-related components associated with fall history.

Methods

This cross-sectional clinical study included 298 middle-aged and older inpatients who underwent sarcopenia assessment, fall history collection, anthropometric measurements, nutritional assessment, laboratory testing, and bone health evaluation. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia 2019 criteria. Fall history was defined as at least one self-reported fall in the past 12 months prior to assessment. Binary logistic regression models were used to evaluate the association between sarcopenia and fall history, with progressive adjustment for age, sex, BMI, number of comorbidities, polypharmacy, Mini Nutritional Assessment total score, and osteoporosis status.

Associations between individual sarcopenia-related components and fall history were further examined.

Results

Among the 298 participants, 125 were classified as having sarcopenia and 73 had a history of falls. Participants with sarcopenia had a higher prevalence of fall history than those without sarcopenia (32.0% vs. 19.1%, P = 0.010). In the fully adjusted model, sarcopenia remained significantly associated with fall history after adjustment for age, sex, BMI, comorbidity burden, polypharmacy, nutritional status, and osteoporosis (OR = 3.548, 95% CI 1.682 to 7.482, P = 0.001). In component analyses, lower appendicular skeletal muscle mass index (OR = 1.948 per 1 kg/m² decrease, 95% CI 1.190 to 3.191, P = 0.008), low muscle mass (OR = 2.799, 95% CI 1.467 to 5.340, P = 0.002), and smaller calf circumference (OR = 1.180 per 1 cm decrease, 95% CI 1.049 to 1.326, P = 0.006) were significantly associated with fall history.

Handgrip strength, low handgrip strength, gait speed, and low gait speed were not significantly associated with fall history.

Conclusion

Sarcopenia was significantly associated with fall history in middle-aged and older adults, independent of nutritional status, osteoporosis, comorbidity burden, and polypharmacy. Low muscle mass and smaller calf circumference were the sarcopenia-related components most clearly associated with fall history. These findings support the importance of evaluating sarcopenia-related fall susceptibility.

Publication and source details

Original title: Association between sarcopenia and fall history in middle-aged and older adults: a multidimensional clinical analysis of nutritional status, bone health, and medication burden

Pin Wang; Jie Ke; Jingjing Wang; Jingyan Chen; Lei Zhang; Yan Yang

Frontiers in Endocrinology · 2026

* Correspondence: Yan Yang, yangyannf@med.uestc.edu.cn; Lei Zhang, 1632147793@qq.com

†These authors have contributed equally to this work and share first authorship

‡These authors have contributed equally to this work

Copyright © 2026 Wang, Ke, Wang, Chen, Zhang and Yang.2026Wang, Ke, Wang, Chen, Zhang and Yanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was supported by a grant from The Research Project on Cadre Health in Sichuan Province (2023-204).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:55:35.020129+00:00

DOI: 10.3389/fendo.2026.1906385 · PMC13506441